The Role for Immunotherapy in Patients with a Driver Mutation Lung Cancer

GRACE

cancergrace.org

The Role for Immunotherapy in Patients with a Driver Mutation Lung Cancer

By GRACE FEATURING Nathan Pennell

19 views

January 17, 2019

Comments 0

Case-Based Panel: Managing EGFR Exon 21 L858R mNSCLC and Insights Fr…

GRACE

A. Saxena, E. Singhi, I. Preeshagul, N. Rohs

19 views

New

Case-Based Panel: Treating 70 y/o Female With SCLC and Insights From…

GRACE

E. Singhi, N. Rohs, A. Saxena, I. Preeshagul

88 views

New

Case-Based Panel: Managing EGFR Exon 19 Lung Cancer and Insights Fro…

GRACE

N. Rohs, A. Saxena, E. Singhi, I. Preeshagul

60 views

Repeat Biopsy in KRAS+ NSCLC

GRACE

J. Luo

82 views

Biopsies in Lung Cancer: Tumor vs. Liquid

GRACE

J. Luo

186 views

Treatment Strategies for KRAS+ NSCLC

GRACE

J. Luo

71 views

An Overview of KRAS+ NSCLC and Diagnostic Testing

GRACE

J. Luo

91 views

Targeted Therapy in Lung Cancer: Side Effects

GRACE

T. Patil

80 views

Targeted Therapy in Lung Cancer: The Importance of Biomarkers

GRACE

T. Patil

99 views

Lung Resection in Early Stage NSCLC: An Overview

GRACE

C. Jeffrey Yang

258 views

Future Goals of mNSCLC Treatment

GRACE

P. Iyengar

64 views

The NRG-LU Trial: Maintenance Systemic Therapy vs. Local Consolidati…

GRACE

P. Iyengar

54 views

Using Radiation to Improve Outcomes and QoL in Patients With mNSCLC

GRACE

P. Iyengar

9 views

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

593 views

Biomarkers in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

198 views

Perioperative vs. Preoperative Surgery in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

408 views

Antibody Drug Conjugates and How They Are Used in NSCLC

GRACE

L. Bazhenova

31 views

ADC Treatment in NSCLC

GRACE

L. Bazhenova

22 views

Bispecific Antibodies in Lung Cancer

GRACE

L. Bazhenova

19 views

Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Insertion Mutatio…

GRACE

L. Bazhenova

35 views

Treatment Options for EGFR+ NSCLC

GRACE

I. Dagogo-Jack, N. Vokes

33 views

Surgical Options for Stage IV NSCLC With Brain Metastases: 60 y/o Wo…

GRACE

I. Dagogo-Jack, J. Reuss

12 views

Neoadjuvant Chemo +/- Nivo for Patients With Early Stage NSCLC: Case…

GRACE

I. Dagogo-Jack, J. Reuss

89 views

Treating Stage III NSCLC: Case-Based Panel Discussion

GRACE

I. Dagogo-Jack, K. Arbour

21 views

How Oncologists Stage Disease - Case-Based Panel Discussion: 50 y/o …

GRACE

I. Dagogo-Jack, J. Reuss, N. Vokes, K. Arbour

20 views

Is Broad NGS the Standard of Care in Advanced NSCLC?

GRACE

I. Dagogo-Jack, M. Marmarelis, A. Sacher, A. Hegde

133 views

Neoadjuvant Therapy vs. Adjuvant Therapy in NSCLC: What Is the Futur…

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

102 views

Surgical vs. Nonsurgical Treatment in Early NSCLC

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

89 views

Early Stage NSCLC: PD-L1 and Durvalumab

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

85 views

Testing in Potentially Resectable & Unresectable Locally Advanced NS…

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

96 views

The Need for Broad Molecular Testing for Driver Mutations in NSCLC

GRACE

J. Gainor

107 views

NSCLC Frontline Therapy for Uncommon Mutations: Overview of RET, NTR…

GRACE

J. Gainor

108 views

Expert Discussion on Targeted Therapy for mNSCLC: Can ALK Inhibitors…

GRACE

J. West

38 views

A Case of a NSCLC KRAS 71 y/o Female With Underlying Autoimmune Cond…

GRACE

S. Liu, J. Brahmer, B. Levy

76 views

Expert Analysis of 1L EGFR+ Advanced NSCLC Options: 1st Gen Gefitini…

GRACE

J. Weiss

205 views

Targeted Therapy for EGFR+ NSCLC: How Do We Think About Acquired Res…

GRACE

Z. Piotrowska

114 views

Targeted Therapy for EGFR+ NSCLC: What Are the Current Options Upon …

GRACE

Z. Piotrowska

104 views

ASCO Expert Discussion on Malignant Pleural Mesothelioma: Does Durva…

GRACE

J. West, H. Yu, D. Spigel

29 views

ASCO Roundtable on 2L Malignant Pleural Mesothelioma: How Encouragin…

GRACE

J. West, H. Yu, D. Spigel

103 views

IO for Unresectable Stage 3 NSCLC: Does Durvalumab Help Patients? Wh…

GRACE

M. Das

66 views

2020 ASCO Highlights on RT+ Chemo in LS-SCLC: Is There a Difference …

GRACE

J. West, H. Yu, D. Spigel

63 views

2020 ASCO ADAURA Trial Update on Adjuvant Osimertinib in EGFR+ NSCLC…

GRACE

H. Yu, D. Spigel, J. West

195 views

2020 ASCO Update on 1L Advanced NSCLC: Is Nivo + Ipi + Limited Cours…

GRACE

H. Yu, D. Spigel, J. West

110 views

2020 ASCO Update on Advanced NSCLC: What Is the Role for Nivolumab/I…

GRACE

H. Yu, D. Spigel, J. West

129 views

2020 ASCO Update on MET/RET+ NSCLC: How Promising Are Capmatinib & P…

GRACE

H. Yu, D. Spigel, J. West

119 views

2020 ASCO Update on HER2+ NSCLC: Is There a Promising Clinical Activ…

GRACE

H. Yu, D. Spigel, J. West

19 views

2020 ASCO Update on EGFR+ NSCLC: Does Upfront SBRT to Sites at Diagn…

GRACE

H. Yu, D. Spigel, J. West

571 views

ASCO 2020 Updates on PD-L1 NSCLC: Is Tiragolumab+Atezo Beneficial fo…

GRACE

J. West, H. Yu, D. Spigel

77 views

2020 Updates on SCLC: Have We Progressed in the Treatment of Relapse…

GRACE

T. Owonikoko

226 views

Liquid Biopsy in NSCLC: Does Adding Liquid Biopsy to Tissue Testing …

GRACE

C. Aggarwal

267 views

SCLC Updates: What Are the Leading Immunotherapy Options?

GRACE

S. Liu

314 views

Expert Discussion on mNSCLC: What Are the Leading Treatment Options …

GRACE

S. Liu

340 views

2020 Update on Molecular Abnormalities in NSCLC: How Do MET Exon 14 …

GRACE

J. Bauml

248 views

The Role of IO for NSCLC Patients With Driver Mutations: What Data D…

GRACE

B. Levy

192 views

2020 Update on Targeted Therapies in NSCLC PD-L1 Expression: What Ar…

GRACE

M. Das

112 views

Non-Small Cell Lung Cancer: Is Immunotherapy Safe for Frail Patients…

GRACE

M. Gubens

55 views

Does Immunotherapy Have Activity in Malignant Pleural Mesothelioma?

GRACE

M. Das

207 views

Non-Small Cell Lung Cancer: How Does a Positive HER2 Mutation Affect…

GRACE

J. West, J. Riess, S. Padda

18 views

ALK+ NSCLC With High PD-L1. What Is the First Line Treatment for Pot…

GRACE

J. West, J. Riess, S. Padda

137 views

What Is the Importance of MET Amplification Level in EGFR+ NSCLC Wit…

GRACE

C. McCoach, H. Wakelee, J. West

11 views

NSCLC EGFR Mutation Treated With Tagrisso: Progression While on Trea…

GRACE

C. McCoach, H. Wakelee, J. West

11 views

NSCLC EGFR Mutation and the FLAURA Trial: Is There a Difference in D…

GRACE

C. McCoach, H. Wakelee, J. West

15 views

EGFR + NSCLC: Is There a Place for Chemo and the Inclusion of Immuno…

GRACE

J. West, H. Wakelee, C. McCoach

746 views

EGFR Mutation and High and High PD-L1 in NSCLC: What is the Role of …

GRACE

C. McCoach, H. Wakelee, J. West

16 views

Non-Small Cell Lung Cancer: What Are the Recommended Treatments for …

GRACE

C. McCoach, H. Wakelee, J. West

123 views

NSCLC With EGFR Mutation: What Are the Treatment Options with Oligop…

GRACE

C. McCoach, H. Wakelee, J. West

11 views

NSCLC With EGFR Mutation: Is There a Place for Chemotherapy and an E…

GRACE

C. McCoach, H. Wakelee, J. West

525 views

NSCLC With EGFR Uncommon Exon 20 Mutation: Suggested Treatments, Tar…

GRACE

C. McCoach, H. Wakelee, J. West

20 views

The Challenges of Potential Pneumonitis Following Durvalumab in Stag…

GRACE

M. Gubens, J. West, M. Das

18 views

Would IO Be Beneficial for Stage 3 NSCLC Patient with PDL1-0 After S…

GRACE

M. Gubens, J. West, M. Das

135 views

Best Schedule for Durvalumab for Older Patient in Stage 3 NSCLC Afte…

GRACE

J. West, M. Gubens, M. Das

235 views

Unresectable NSCLC: What Is TMB and Does it Add Significant Benefit …

GRACE

M. Gubens, J. West, M. Das

470 views

Does Checkmate 227's Suggestion of an IO Combination of Ipi + Nivo O…

GRACE

M. Gubens, J. West, M. Das

131 views

Should Molecular Tests Be Considered in Stage 3 NSCLC and Would Outc…

GRACE

M. Gubens, J. West, M. Das

323 views

Case of 60 y/o Woman with ALK Positive Metastatic NSCLC: Approach to…

GRACE

S. Padda, J. Riess, J. West

197 views

Case of ALK Positive Patient with Asymptomatic Brain Metastases: Is …

GRACE

S. Padda, J. Riess, J. West

17 views

Treatment for NSCLC Patient Who Developed Resistance to ALK Inhibito…

GRACE

S. Padda, J. Riess, J. West

18 views

Is the Standard Treatment the Best Approach for Stage 3 Frail Patien…

GRACE

M. Gubens, J. West, M. Das

396 views

Should We Continue the ALK Inhibitor in NSCLC Patient with Brain Met…

GRACE

S. Padda, J. Riess, J. West

126 views

Is There a Role for Combination Therapies Like Chemo/Radio and IO fo…

GRACE

S. Padda, J. Riess, J. West

337 views

Stage 3 NSCLC - Standard Concurrent Chemo + Radiation, Followed by I…

GRACE

M. Gubens, J. West, M. Das

176 views

Stage 3 NSCLC: Is the Standard Treatment of Chemo and Radiation Foll…

GRACE

M. Gubens, J. West, M. Das

281 views

Case Based Discussion on Stage 3 NSCLC: Should We Do Molecular Tests…

GRACE

M. Gubens, J. West, M. Das

347 views

CancerGRACE's ASCO 2019 Update on Lung Cancer: How Promising is Lurb…

GRACE

J. West, B. Levy, C. Aggarwal

877 views

CancerGRACE's ASCO 2019 Update on Lung Cancer: Short Discussion on K…

GRACE

J. West, B. Levy, C. Aggarwal

178 views

CancerGRACE's ASCO 2019 Update on Lung Cancer: Circulating Tumor DNA…

GRACE

J. West, B. Levy, C. Aggarwal

95 views

CancerGRACE's ASCO 2019 Update on Lung Cancer: Retrospective Analysi…

GRACE

J. West, B. Levy, C. Aggarwal

99 views

CancerGRACE's ASCO 2019 Update on Stage IV NSCLC: New Targets - RET

GRACE

J. West, B. Levy, C. Aggarwal

148 views

CancerGRACE's ASCO 2019 Highlights and New Approaches in Stage IV NS…

GRACE

J. West, B. Levy, C. Aggarwal

283 views

CancerGRACE's ASCO 2019 Highlights and New Approaches in Stage IV NS…

GRACE

J. West, B. Levy, C. Aggarwal

69 views

CancerGRACE's 2019 ASCO Highlights in Advanced NSCLC: What is the Lo…

GRACE

J. West, B. Levy, C. Aggarwal

224 views

CancerGRACE's 2019 ASCO Highlights on Adjuvant Afatinib in Stage II …

GRACE

J. West, B. Levy, C. Aggarwal

470 views

CancerGRACE's 2019 ASCO Highlights on Stage I NSCLC Adjuvant Chemoth…

GRACE

J. West, B. Levy, C. Aggarwal

25 views

Is There a Role for IO in EGFR+ Metastatic Lung Cancer?

GRACE

H. Yu

4.8K views

Initial Treatment and Acquired Resistance in Advanced Lung Cancer & …

GRACE

J. Bauml, J. Sabari

208 views

Q&A on Targeted Therapies in Advanced Lung Cancer

GRACE

J. Bauml

15 views

Introduction to Next Generation Sequencing in Metastatic Lung Cancer…

GRACE

J. Bauml

626 views

EGFR Initial Treatment and Acquired Resistance in Advanced NSCLC

GRACE

H. Yu

179 views

Q&A on EGFR Initial Treatment and Acquired Resistance in Advanced NS…

GRACE

H. Yu

33 views

Optimal First Line Treatment of EGFR+ Advanced NSCLC: First and Seco…

GRACE

J. West

113 views

Optimal First Line Treatment of EGFR+ Advanced NSCLC: Osimertinib vs…

GRACE

J. West

558 views

Optimal First Line Treatment of EGFR+ Advanced NSCLC: Dacomitinib, E…

GRACE

J. West

676 views

Targeted Therapies in Advanced Lung Cancer: What is the Role of Rebi…

GRACE

H. Borghaei

462 views

Discussion/Q&A on Targeted Therapies in Advanced Lung Cancer

GRACE

H. Borghaei

24 views

Targeted Therapies in Metastatic NSCLC: Liquid Biopsies as a New Opt…

GRACE

C. Aggarwal

623 views

Immunotherapy in Stage lll NSCLC - The Pacific Trial and Imfinzi

GRACE

K. Kelly

167 views

Tumor Mutation Burden in Patients with Non-Squamous NSCLC: Current S…

GRACE

S. Patel

20 views

Evolving Standards for Molecular Testing in Advanced NSCLC

GRACE

S. Patel

21 views

Combinations of Immunotherapy Agents in Advanced NSCLC: Current Stat…

GRACE

S. Patel

18 views

The Basics of Managing Immune-Mediated Side Effects in NSCLC

GRACE

S. Patel

24 views

What Should Patients With Rapid Progression in Advanced NSCLC Throug…

GRACE

J. West

190 views

"Consolidation" Radiation After a Good Response to First Line Therap…

GRACE

J. West

14 views

Chemotherapy and Immunotherapy Combinations in Advanced Non-Squamous…

GRACE

J. West

164 views

Chemo Immuno Therapy Combinations in Advanced Squamous NSCLC

GRACE

J. West

179 views

Does Immunotherapy Work in Patients with Driver Mutations Like EGFR …

GRACE

J. West

237 views

EGFR TKI Gilotrif(Afatinib) in Metastatic Squamous NSCLC

GRACE

V. Velcheti

201 views

Lung Cancer Immunotherapy- Is There Anything Better than PDL1

GRACE

V. Velcheti

114 views

MET as a Target in Advanced NSCLC

GRACE

V. Velcheti

24 views

The Changing Landscape of 1L Treatment of ALK-Positive Advanced NSCL…

GRACE

A. Shaw

45 views

Patterns of Resistance in ALK Positive NSCLC

GRACE

A. Shaw

227 views

Controlling Brain Metastases in Patients with Molecular Driven Advan…

GRACE

A. Shaw

30 views

Immunotherapy for Previously Treated Patients with NSCLC

GRACE

K. Reckamp

16 views

New Options in Acquired Resistance for ALK+ Metastatic Non-small Cel…

GRACE

N. Pennell

235 views